Clinical Trial Update: A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis [Phase 4]

View source ↗

Summary

Phase 4 study comparing Lastacaft (olopatadine) to Pataday (olopatadine) and placebo for efficacy in acute allergic conjunctivitis; results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Lastacaft (Alcaftadine)
• Pataday (olopatadine)

Snippet

Sponsor: Allergan | Conditions: Conjunctivitis, Allergic | Phase 4 | Status: COMPLETED | Results posted: 2014-01-14